Refine
Has Fulltext
- yes (57)
Is part of the Bibliography
- yes (57)
Year of publication
Document Type
- Journal article (57)
Language
- English (57)
Keywords
- Parkinson’s disease (15)
- deep brain stimulation (13)
- Parkinson's disease (8)
- subthalamic nucleus (6)
- dopamine (5)
- neuroinflammation (5)
- basal ganglia (4)
- cervical dystonia (3)
- ischemic stroke (3)
- length of stenosis (3)
- mesencephalic locomotor region (3)
- neurodegeneration (3)
- photothrombotic stroke (3)
- stroke (3)
- tremor (3)
- Parkinson disease (2)
- T cells (2)
- base of support (2)
- carotid atherosclerosis (2)
- carotid stenosis (2)
- carotid ultrasound (2)
- cerebellar tDCS (2)
- degree of stenosis (2)
- dementia (2)
- disease (2)
- dystonia (2)
- essential tremor (2)
- gait (2)
- gait initiation (2)
- local field potentials (2)
- locus coeruleus (2)
- movement disorders (2)
- multiple sclerosis (2)
- neuroprotection (2)
- outcomes (2)
- second hit (2)
- split-belt treadmill (2)
- walking (2)
- 5IA-SPECT (1)
- A53T (1)
- Alzheimer’s disease (1)
- Amplitude (1)
- BDNF (1)
- Braak (1)
- DARPA (1)
- DBS biomarkers (1)
- DBS programming (1)
- DOPA-responsive-dystonia (1)
- DRD1 (1)
- DYT1 (1)
- Dystonia (1)
- F-18-FDG PET (1)
- GCH1 (1)
- GFAP (1)
- GFAP-astrocytopathies (1)
- GPCR (1)
- LSVT-big therapy (1)
- Lewy-like pathology (1)
- MCC950 (1)
- MIBG scintigraphy (1)
- NLRP3 (1)
- NPC1 gene (1)
- NPC2 gene (1)
- Niemann–Pick disease type C (1)
- Parkinson (1)
- Parkinsons disease (1)
- Parkionson's disease (1)
- Pointing error (1)
- Proprioception (1)
- Tourette syndrome (1)
- Training (1)
- TrkB (1)
- [18F]FDG positron emission tomography (1)
- accuracy (1)
- adult-onset (1)
- alpha-7 nicotinic acetylcholine receptor (1)
- ankles (1)
- anthropometric measurement (1)
- anthropometric measurements (1)
- antigen-presenting cells (1)
- apomorphine (1)
- areas (1)
- arm (1)
- autoantibodies (1)
- balance (1)
- beta oscillation (1)
- beta oscillations (1)
- beta power (1)
- bilateral internal carotid artery stenosis (1)
- binding (1)
- biological locomotion (1)
- blood-brain barrier (1)
- botulinum toxin (1)
- brain (1)
- brain metabolic alterations (1)
- brain networks (1)
- brain stem (1)
- care tempis (1)
- cerebellum (1)
- children (1)
- choline acetyltransferase (1)
- cholinergic activity (1)
- chronic stimulation (1)
- clinical approach (1)
- clinical diagnosis (1)
- clinical outcome (1)
- closed-loop (1)
- cognitive decline (1)
- coherence analysis (1)
- computer vision (1)
- consolidation (1)
- continuous theta burst stimulation (cTBS) (1)
- coordination (1)
- cortical excitability (1)
- cortical silent period (1)
- cortico-striatal synapse (1)
- criteria (1)
- dSPN (1)
- deep brain stimulation (DBS) (1)
- depression (1)
- diagnostic markers (1)
- digital medicine (1)
- direct pathway (1)
- directional deep brain stimulation (1)
- dopamine acetylcholine (1)
- dopaminergic cells (1)
- duodenal levodopa infusion (1)
- exome sequencing (1)
- experimental stroke (1)
- eye movement disorders (1)
- family caregiver (1)
- freezing of gait (1)
- freezing of gait (FOG) (1)
- functional MRI (1)
- functional neuroanatomy (1)
- future directions (1)
- gene-environment interaction (1)
- globus pallidus pars interna (GPi) (1)
- guidelines (1)
- high contrast (1)
- hospitals (1)
- human neurons (1)
- image-guided programming (1)
- imaging (1)
- induced neural stem cells (1)
- infarction volume (1)
- inflammasome (1)
- informal care (1)
- internal carotid artery stenosis (1)
- invasive electric stimulation (1)
- just noticeable difference (JND) (1)
- kinematics (1)
- levodopa-induced dyskinesia (1)
- locomotor adaptation (1)
- major depression (1)
- microglia (1)
- mortality (1)
- motor control (1)
- motor learning (1)
- motor-evoked potentials (MEP) (1)
- mouse model (1)
- movement (1)
- movement disorder (1)
- movements (1)
- multiple system atrophy (1)
- musical syntax (1)
- mutation (1)
- neuroimmunology (1)
- neurology (1)
- neuronal apoptosis (1)
- neuronal network (1)
- neurophysiology (1)
- neuroscience (1)
- nicotinic receptors (1)
- non-motor features (1)
- noradrenalin (1)
- noradrenaline (1)
- norepinephrine (1)
- nucleus ventralis intermedius (1)
- nystagmus (1)
- outcome (1)
- pallidal stimulation (1)
- parkinson disease (1)
- parkinsons disease (1)
- pathophysiology (1)
- pedunculopontine nucleus (PPN) (1)
- peripheral injury (1)
- peripheral nervous system (1)
- pet (1)
- photothrombosis (1)
- physical therapy modalities (1)
- pilot project (1)
- plaque cross-sectional area (1)
- plasma oxysterols (1)
- post-traumatic stress disorder (1)
- posture (1)
- precision medicine (1)
- progression (1)
- psychophysics (1)
- quality (1)
- randomized controlled double-blind study (1)
- randomized controlled trial (1)
- rat (1)
- reach-to-grasp movement (1)
- regulatory T cells (1)
- reserpinized rat model (1)
- resting tremor (1)
- rett (1)
- rhythm perception (1)
- risk (1)
- risk of fall (1)
- segmental centers of mass (1)
- skilled forelimb movements (1)
- skin biopsy (1)
- soleus muscles (1)
- spinal-cord (1)
- stimulation (1)
- stroke care (1)
- subthalamic nucleus (STN) (1)
- synapse (1)
- synaptic plasticity (1)
- synaptic vesicles (1)
- syndrome (1)
- target considerations (1)
- telemedicine (1)
- telemedicine network (1)
- term follow-up (1)
- thrombolysis (1)
- tight junctions (1)
- time (1)
- time perception (1)
- transcranial magnetic simulation (TMS) (1)
- transient ischemic attack (1)
- transmission electron microscopy (1)
- treatment-resistant depression (1)
- velocity (1)
- vertebrobasilar insufficiency (1)
- vertigo (1)
- vestibular (1)
- videooculography (1)
- white matter lesions (1)
- α-synuclein (1)
- α-synuclein-specific T cells (1)
Institute
- Neurologische Klinik und Poliklinik (57)
- Klinik und Poliklinik für Nuklearmedizin (9)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (5)
- Neurochirurgische Klinik und Poliklinik (5)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Institut für Klinische Neurobiologie (3)
- Institut für Virologie und Immunbiologie (3)
- Institut für Anatomie und Zellbiologie (2)
- Pathologisches Institut (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
The size of the synaptic subcomponents falls below the limits of visible light microscopy. Despite new developments in advanced microscopy techniques, the resolution of transmission electron microscopy (TEM) remains unsurpassed. The requirements of tissue preservation are very high, and human post mortem material often does not offer adequate quality. However, new reprogramming techniques that generate human neurons in vitro provide samples that can easily fulfill these requirements. The objective of this study was to identify the culture technique with the best ultrastructural preservation in combination with the best embedding and contrasting technique for visualizing neuronal elements. Two induced neural stem cell lines derived from healthy control subjects underwent differentiation either adherent on glass coverslips, embedded in a droplet of highly concentrated Matrigel, or as a compact neurosphere. Afterward, they were fixed using a combination of glutaraldehyde (GA) and paraformaldehyde (PFA) followed by three approaches (standard stain, Ruthenium red stain, high contrast en-bloc stain) using different combinations of membrane enhancing and contrasting steps before ultrathin sectioning and imaging by TEM. The compact free-floating neurospheres exhibited the best ultrastructural preservation. High-contrast en-bloc stain offered particularly sharp staining of membrane structures and the highest quality visualization of neuronal structures. In conclusion, compact neurospheres growing under free-floating conditions in combination with a high contrast en-bloc staining protocol, offer the optimal preservation and contrast with a particular focus on visualizing membrane structures as required for analyzing synaptic structures.
Cervical dystonia (CD) is a movement disorder which affects daily living of many patients. In clinical practice, several unmet treatment needs remain open. This article focuses on the four main aspects of treatment. We describe existing and emerging treatment approaches for CD, including botulinum toxin injections, surgical therapy, management of non-motor symptoms, and rehabilitation strategies. The unsolved issues regarding each of these treatments are identified and discussed, and possible future approaches and research lines are proposed.
Background
Telemedicine improves the quality of acute stroke care in rural regions with limited access to specialized stroke care. We report the first 2 years' experience of implementing a comprehensive telemedical stroke network comprising all levels of stroke care in a defined region.
Methods
The TRANSIT-Stroke network covers a mainly rural region in north-western Bavaria (Germany). All hospitals providing acute stroke care in this region participate in TRANSIT-Stroke, including four hospitals with a supra-regional certified stroke unit (SU) care (level III), three of those providing teleconsultation to two hospitals with a regional certified SU (level II) and five hospitals without specialized SU care (level I). For a two-year-period (01/2015 to 12/2016), data of eight of these hospitals were available; 13 evidence-based quality indicators (QIs) related to processes during hospitalisation were evaluated quarterly and compared according to predefined target values between level-I- and level-II/III-hospitals.
Results
Overall, 7881 patients were included (mean age 74.6 years +/- 12.8; 48.4% female). In level-II/III-hospitals adherence of all QIs to predefined targets was high ab initio. In level-I-hospitals, three patterns of QI-development were observed: a) high adherence ab initio (31%), mainly in secondary stroke prevention; b) improvement over time (44%), predominantly related to stroke specific diagnosis and in-hospital organization; c) no clear time trends (25%). Overall, 10 out of 13 QIs reached predefined target values of quality of care at the end of the observation period.
Conclusion
The implementation of the comprehensive TRANSIT-Stroke network resulted in an improvement of quality of care in level-I-hospitals.
Deep brain stimulation (DBS) of the subthalamic nucleus or the globus pallidus is an established treatment for Parkinson’s disease (PD) that yields a marked and lasting improvement of motor symptoms. Yet, DBS benefit on gait disturbances in PD is still debated and can be a source of dissatisfaction and poor quality of life. Gait disturbances in PD encompass a variety of clinical manifestations and rely on different pathophysiological bases. While gait disturbances arising years after DBS surgery can be related to disease progression, early impairment of gait may be secondary to treatable causes and benefits from DBS reprogramming. In this review, we tackle the issue of gait disturbances in PD patients with DBS by discussing their neurophysiological basis, providing a detailed clinical characterization, and proposing a pragmatic programming approach to support their management.
Isolated generalized dystonia is a central motor network disorder characterized by twisted movements or postures. The most frequent genetic cause is a GAG deletion in the Tor1a (DYT1) gene encoding torsinA with a reduced penetrance of 30-40 % suggesting additional genetic or environmental modifiers. Development of dystonia-like movements after a standardized peripheral nerve crush lesion in wild type (wt) and Tor1a+/- mice, that express 50 % torsinA only, was assessed by scoring of hindlimb movements during tail suspension, by rotarod testing and by computer-assisted gait analysis. Western blot analysis was performed for dopamine transporter (DAT), D1 and D2 receptors from striatal and quantitative RT-PCR analysis for DAT from midbrain dissections. Autoradiography was used to assess the functional DAT binding in striatum. Striatal dopamine and its metabolites were analyzed by high performance liquid chromatography. After nerve crush injury, we found abnormal posturing in the lesioned hindlimb of both mutant and wt mice indicating the profound influence of the nerve lesion (15x vs. 12x relative to control) resembling human peripheral pseudodystonia. In mutant mice the phenotypic abnormalities were increased by about 40 % (p < 0.05). This was accompanied by complex alterations of striatal dopamine homeostasis. Pharmacological blockade of dopamine synthesis reduced severity of dystonia-like movements, whereas treatment with L-Dopa aggravated these but only in mutant mice suggesting a DYT1 related central component relevant to the development of abnormal involuntary movements. Our findings suggest that upon peripheral nerve injury reduced torsinA concentration and environmental stressors may act in concert in causing the central motor network dysfunction of DYT1 dystonia.
Topological differences and confounders of mental rotation in cervical dystonia and blepharospasm
(2023)
Mental rotation (mR) bases on imagination of actual movements. It remains unclear whether there is a specific pattern of mR impairment in focal dystonia. We aimed to investigate mR in patients with cervical dystonia (CD) and blepharospasm (BS) and to assess potential confounders. 23 CD patients and 23 healthy controls (HC) as well as 21 BS and 19 hemifacial spasm (HS) patients were matched for sex, age, and education level. Handedness, finger dexterity, general reaction time, and cognitive status were assessed. Disease severity was evaluated by clinical scales. During mR, photographs of body parts (head, hand, or foot) and a non-corporal object (car) were displayed at different angles rotated within their plane. Subjects were asked to judge laterality of the presented image by keystroke. Both speed and correctness were evaluated. Compared to HC, CD and HS patients performed worse in mR of hands, whereas BS group showed comparable performance. There was a significant association of prolonged mR reaction time (RT) with reduced MoCA scores and with increased RT in an unspecific reaction speed task. After exclusion of cognitively impaired patients, increased RT in the mR of hands was confined to CD group, but not HS. While the question of whether specific patterns of mR impairment reliably define a dystonic endophenotype remains elusive, our findings point to mR as a useful tool, when used carefully with control measures and tasks, which may be capable of identifying specific deficits that distinguish between subtypes of dystonia.
To determine the role of striatal dopaminergic innervation on upper limb synergies during walking, we measured arm kinematics in 13 subjects with Parkinson disease. Patients were recruited according to several inclusion criteria to represent the best possible in vivo model of dopaminergic denervation. Of relevance, we included only subjects with normal spatio-temporal parameters of the stride and gait speed to avoid an impairment of upper limbs locomotor synergies as a consequence of gait impairment per se. Dopaminergic innervation of the striatum was measured by FP-CIT and SPECT. All patients showed a reduction of gait-associated arms movement. No linear correlation was found between arm ROM reduction and contralateral dopaminergic putaminal innervation loss. Still, a partition analysis revealed a 80% chance of reduced arm ROM when putaminal dopamine content loss was >47%. A significant correlation was described between the asymmetry indices of the swinging of the two arms and dopaminergic striatal innervation. When arm ROM was reduced, we found a positive correlation between upper-lower limb phase shift modulation ( at different gait velocities) and striatal dopaminergic innervation. These findings are preliminary evidence that dopaminergic striatal tone plays a modulatory role in upper-limb locomotor synergies and upper-lower limb coupling while walking at different velocities.
Symptomatic vs. asymptomatic 20–40% internal carotid artery stenosis: Does the plaque size matter?
(2019)
Background: Around 9–15% of ischemic strokes are related to internal carotid artery (ICA)-stenosis ≥50%. However, the extent to which ICA-stenosis <50% causes ischemic cerebrovascular events is uncertain. We examined the relation between plaque cross-sectional area and length and the risk of ischemic stroke or TIA among patients with ICA-stenosis of 20–40%.
Methods: We retrospectively identified patients admitted to the Department of Neurology, University Hospital of Würzburg, from January 2011 until September 2016 with ischemic stroke or TIA and concomitant ICA-stenosis of 20–40%, either symptomatic or asymptomatic. Plaque length and cross-sectional area were assessed on ultrasound scans.
Results: We identified 41 patients with ischemic stroke or TIA and ICA-stenosis of 20–40%; 14 symptomatic and 27 asymptomatic. The plaque cross-sectional area was significantly larger among symptomatic than asymptomatic ICA-stenosis; median values (IQR) were 0.45 (0.21–0.69) cm2 and 0.27 (0.21–0.38) cm2, p = 0.03, respectively. A plaque cross-sectional area ≥0.36 cm2 had a sensitivity of 71% and a specificity of 76% for symptomatic compared with asymptomatic ICA-stenosis. In a sex-adjusted multivariate logistic regression, a plaque cross-sectional area ≥0.36 cm2 and a plaque length ≥1.65 cm were associated with an OR (95% CI) of 5.54 (1.2–25.6), p = 0.028 and 1.78 (0.36–8.73), p = 0.48, respectively, for symptomatic ICA-stenosis.
Conclusion: Large plaques might increase the risk of ischemic stroke or TIA among patients with low-grade ICA-stenosis of 20–40%. Sufficiently powered prospective longitudinal cohort studies are needed to definitively test the stroke risk stratification value of carotid plaque length and cross-sectional area in the setting of current optimal medical treatment.
Activation of the basal ganglia has been shown during the preparation and execution of movement. However, the functional interaction of cortical and subcortical brain areas during movement and the relative contribution of dopaminergic striatal innervation remains unclear. We recorded local field potential (LFP) activity from the subthalamic nucleus (STN) and high-density electroencephalography (EEG) signals in four patients with Parkinson’s disease (PD) off dopaminergic medication during a multi-joint motor task performed with their dominant and non-dominant hand. Recordings were performed by means of a fully-implantable deep brain stimulation (DBS) device at 4 months after surgery. Three patients also performed a single-photon computed tomography (SPECT) with [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (FP-CIT) to assess striatal dopaminergic innervation. Unilateral movement execution led to event-related desynchronization (ERD) followed by a rebound after movement termination event-related synchronization (ERS) of oscillatory beta activity in the STN and primary sensorimotor cortex of both hemispheres. Dopamine deficiency directly influenced movement-related beta-modulation, with greater beta-suppression in the most dopamine-depleted hemisphere for both ipsi- and contralateral hand movements. Cortical-subcortical, but not interhemispheric subcortical coherencies were modulated by movement and influenced by striatal dopaminergic innervation, being stronger in the most dopamine-depleted hemisphere. The data are consistent with a role of dopamine in shielding subcortical structures from an excessive cortical entrapment and cross-hemispheric coupling, thus allowing fine-tuning of movement.
Background and Purpose: Internal carotid artery stenosis (ICAS)≥70% is a leading cause of ischemic cerebrovascular events (ICVEs). However, a considerable percentage of stroke survivors with symptomatic ICAS (sICAS) have <70% stenosis with a vulnerable plaque. Whether the length of ICAS is associated with high risk of ICVEs is poorly investigated. Our main aim was to investigate the relation between the length of ICAS and the development of ICVEs.
Methods: In a retrospective cross-sectional study, we identified 95 arteries with sICAS and another 64 with asymptomatic internal carotid artery stenosis (aICAS) among 121 patients with ICVEs. The degree and length of ICAS as well as plaque echolucency were assessed on ultrasound scans.
Results: A statistically significant inverse correlation between the ultrasound-measured length and degree of ICAS was detected for sICAS≥70% (Spearman correlation coefficient ρ = –0.57, p < 0.001, n = 51) but neither for sICAS<70% (ρ = 0.15, p = 0.45, n = 27) nor for aICAS (ρ = 0.07, p = 0.64, n = 54). The median (IQR) length for sICAS<70% and ≥70% was 17 (15–20) and 15 (12–19) mm (p = 0.06), respectively, while that for sICAS<90% and sICAS 90% was 18 (15–21) and 13 (10–16) mm, respectively (p < 0.001). Among patients with ICAS <70%, a cut-off length of ≥16 mm was found for sICAS rather than aICAS with a sensitivity and specificity of 74.1% and 51.1%, respectively. Irrespective of the stenotic degree, plaques of the sICAS compared to aICAS were significantly more often echolucent (43.2 vs. 24.6%, p = 0.02).
Conclusion: We found a statistically insignificant tendency for the ultrasound-measured length of sICAS<70% to be longer than that of sICAS≥70%. Moreover, the ultrasound-measured length of sICAS<90% was significantly longer than that of sICAS 90%. Among patients with sICAS≥70%, the degree and length of stenosis were inversely correlated. Larger studies are needed before a clinical implication can be drawn from these results.